Forskning ved Københavns Universitet - Københavns Universitet

Forside

B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Graves' disease (GD) is a common TSH receptor autoantibody (TRAb)-mediated disorder. Because B lymphocytes are important self-antigen presenting cells and precursors for antibody-secreting plasma cells, temporary B-lymphocyte depletion with the monoclonal antibody rituximab (RTX) might be of benefit in GD.
OriginalsprogEngelsk
TidsskriftJournal of Clinical Endocrinology and Metabolism
Vol/bind92
Udgave nummer5
Sider (fra-til)1769-72
Antal sider4
ISSN0021-972X
DOI
StatusUdgivet - 1 maj 2007

ID: 34072611